Medical Technologies

Medical Technology (MedTech) is an important growth sector for Singapore and has been identified as a key pillar for A*STAR to advance Singapore’s national priorities in improving health outcomes, and foster innovation and economic development within the region.

The ambition is for A*STAR to be the MedTech nexus for the nation and support the development of commercially viable MedTech products.

Our Playbook

A*STAR's MedTech playbook focuses on supporting integrated healthcare of the future through 5 thematic innovation pillars and 5 key enablers.

Innovation Pillars

Explore thematic innovation pillars drawing on the multi-disciplinary capabilities of A*STAR.

Learn More

Enablers

Discover our key enablers propelling R&D efforts towards product and market.

Learn More

People

Find out more about how MedTech is organised in A*STAR and our leading principal investigators.

Learn More

Latest News

1/7

NUS, A*STAR researchers develop sensor that can detect cholesterol and...

MedTech Holds Dual Promise of Healthcare and Economic Progress for Sin...

$38M MedTech Catapult Initiative Announced in Ministry of Trade and In...

A signing ceremony to officiate the A*STAR-EVYD Joint Lab was held in Singapore to signify the commitment to develop AI solutions for population and digital health.

EVYD and A*STAR Open Joint Lab with A S$10 Million Collaboration to Ad...

GE HealthCare inks MoU with A*STAR's Institute of Materials Research a...

SingHealth and A*STAR Establish S$8 Million Partnership to Co-develop...

MiRXES opens S$8m in-vitro diagnostic manufacturing facility

“The SingHealth-A*STAR HTP synergises SingHealth’s strengths in clinical care and healthcare innovation and A*STAR’s expertise in science and technology to catalyse the development of new solutions through research and innovation, and empower healthcare researchers and innovators to better leverage emerging technologies that will bring about better care outcomes for our patients and the population.”

Professor Ivy Ng

Group CEO, Singhealth

“A*STAR has been a key supporter of Respiree from the times when the core technology was conceived in the Laboratory of Bio-optical Imaging at SBIC. This includes the development of and provision of funding for technology development, the licensing of the resultant technology and ultimately the spin-off of Respiree. In addition to assist in financing the development of Respiree, the members of A*ccelerate have played a critical role in supporting fund raising through introduction of suitable investors, regulatory advice and mentorship in the development and commercialisation of Respiree.”

Dr Gurpreet Singh

CEO, Respiree

“MiRXES i4.0 IVD manufacturing facility aims to contribute towards Singapore’s Manufacturing 2030 vision together with esteemed partners like A*STAR. Working together, there is great potential for Singapore to become a critical node in the global diagnostics value chain, and I am proud that MiRXES will be part of this legacy, which also has synergy with our goal to be the global leader for IVD manufacturing.”

Dr Lihan Zhou

CEO, MiRXES

"Singapore is at the forefront of medical innovation and R&D- and we value the opportunity to work with Singaporean organisations like A*STAR to develop the next generation of healthcare technology. Leveraging both our strengths has not only resulted in new innovations to GE’s solutions- they are helping to address the fast-growing healthcare needs of Southeast Asia and the world.”

Michael Barber

President and CEO, Molecular Imaging and Computed Tomography, GE Healthcare